Overview
Alzheimer's disease is a progressive neurodegenerative disorder and the most common cause of dementia, characterized by a gradual decline in memory, reasoning, language, and the ability to carry out everyday activities. It is associated with pathological changes in the brain, including the accumulation of amyloid plaques and neurofibrillary tangles, neuronal loss, and atrophy of affected regions such as the medial temporal lobe. The disease usually emerges in later life and advances over years, often passing through stages of mild cognitive impairment before reaching more severe dementia. There is currently no cure; available interventions aim to manage symptoms, support function, and improve quality of life for patients and caregivers. Work appearing in this journal reflects the breadth of contemporary Alzheimer's research, including efforts at early prediction and biomarker discovery, non-pharmacological interventions for problems such as disrupted sleep, and the neurobiology underlying behavioral symptoms like aggression and agitation. Other contributions examine caregiver knowledge and misconceptions, the overlap between depression, cognitive impairment, and temporal lobe atrophy, and molecular mechanisms involving circular RNAs and inflammatory markers. Across these strands, key themes include diagnosis and staging, distinguishing Alzheimer's from related conditions, caregiver education and support, and the search for modifiable risk factors and treatments that may slow or alter disease progression.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Distinguishing between Knowledge Gaps and Misconceptions of Alzheimer’s Disease among Caregivers in the UK
Is Vagus Nerve Therapy a Potential Alzheimer's Disease Treatment?
A Summary of Circular RNAs in Alzheimer's Disease
The Role of Non-Pharmacological Interventions for Disrupted Sleep in the Moderate-Severe Dementia Population: A Systematic Review
JALR. New Journal, Old questions, Fresh insights
Basal Serum Cortisol Levels, Depression and Medial Temporal Lobe Atrophy in Patients with Mild Cognitive Impairment and Alzheimer’s Disease
Epigenetics and Nutrition
Neurobiological Differences Between Aggression and Agitation in Persons with Dementia
Evaluation of Vitamin D3 metabolite (25-OH Vit D3), Neurotransmitter (ACh), and the Expression of Proinflammatory Cytokines (IL-6 and TNF-α) in Tissue Homogenate after Administration of Biofield Energy Healing-based Novel Proprietary Test Formulation and Biofield Treatment per se to the Animals in Vitamin D3 Deficiency Diet (VDD)-induced Sprague Dawley Rats
Why Do Human Body Systems Go Into Catastrophic System Failure Leading to Diseases -Is the Answer in Science or Nature?
How this research is being cited
The 12 articles above have been cited 33 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · BMC Geriatrics
-
2026 · Biochemical Pharmacology
-
2026 · Alcohol and Alcoholism
-
2026 · Nordic Journal of Music Therapy
-
Hami Hemati et al. · 2025 · Brain, behavior, and immunity
-
2025 ·
-
Raymond U. Tan et al. · 2025 · Acta medica Philippina
-
2025 · Brain Behavior and Immunity
A sample of recent works citing this journal's research on Alzheimer s Disease, linking to each citing work.